Zoledronic acid overdose in a two-year-old with osteogenesis imperfecta
AbstractZoledronic acid is an intravenous (IV) bisphosphonate used to treat bone metastases associated with solid tumors and metabolic bone disorders. It is an established treatment option for children with osteogenesis imperfect (OI). Its efficacy relies on its higher potency and affinity for bone,...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2023-12-01
|
| Series: | Toxicology Communications |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/24734306.2023.2260146 |